YK11 Side Effects Explained

Knowing the side effects of YK11 is the first step in beginning your research. This helps avoid its negative effects and streamlines your research. Therefore, we have made this task easy for you. In this blog, we have explained all possible side effects of YK11. Read them before embarking on your laboratory experiment! 

What is YK-11?

Buy YK-11

YK11 is a synthetic compound with potential similar to that of SARMs (Selective Androgen Receptor Modulators). It has been investigated for its potential to influence muscle hypertrophy, skeletal health, and fat metabolism in preclinical settings. Regarding its mechanism of action, it may work in two different ways. First, it may bind with androgen receptors in muscle and bone tissues of preclinical models. This binding may trigger the pathways involved in muscle growth and bone health. Second, it may inhibit the patterns linked to myostatin (a protein that inhibits muscle growth). This potential inhibition of myostatin may impact muscle growth pathways in preclinical models. 

YK-11 Side Effects

Although beneficial in preclinical settings, YK11 may cause some side effects. Here is a detailed overview of the side effects: 

• Hormonal Fluctuation: 

In preclinical settings, researchers observed that YK11 may sometimes impact hormonal fluctuation. When it acts as a potent androgen receptor agonist, YK11 may modulate endogenous hormone signaling pathways in preclinical models. This may affect the levels of testosterone and other androgen hormones in preclinical models. 

• Liver Toxicity: 

Researchers have also hypothesized that YK11 may also impact liver toxicity in preclinical models. This may affect abdominal disturbance, nausea, or elevated liver enzymes in preclinical models. 

• Joint Pain: 

Some preclinical models have also experienced joint pain while investigating on the compound. The joint pain is associated with increased inhibition of myostatin. The inhibition of myostatin may affect muscle mass, which may cause discomfort and inflammation in the joints of preclinical models. 

• Psychological Impact or Mood Changes:

For a balanced mood, there must be balanced hormonal levels. YK11 affects the pathways associated with hormonal functions in preclinical models. This effect on hormonal balance may cause mood changes, such as irritation and emotional instability in research models. 

Factors Influencing YK-11 Side Effects

Some factors may influence YK-11's side effects in laboratory studies. Therefore, we need to understand them one by one. Here are the complete details of these factors:

• Amount of Dosage: 

This refers to the dosage administered to a preclinical model at a given time. In cases of increased or decreased YK-11 dosage, side effects may fluctuate accordingly. 

• Duration of Dosage Cycle: 

This includes the duration of your laboratory experiments. Using YK-11 beyond the recommended duration may alter the potential side effects in the preclinical model. 

• Underlying Health Condition of Preclinical Models: 

Side effects may also appear if the preclinical models used in the experiments have any underlying health issues. These health issues may include chronic illness or other medical conditions. 

• Stacking with Other Compounds: 

This means combining YK-11 with other research compounds. So combining it with other compounds may influence the potential side effects of your research studies. The side effects of other compounds may appear as the adverse side of the research experiment

How to Manage YK-11 Side Effects

To manage side effects of YK11 during laboratory studies, researchers must adhere to the following guidelines: 

• Start From a Low Dose: 

Always start your experiment from a low dose and then gradually increase the amount. This will enable preclinical models to adjust to the dosage for more effective research outcomes. 

• Adhere to the Recommended Dosage and Cycle Length: 

Secondly, researchers must follow all recommended guidelines from the beginning of their research through to the final results. This includes dosage amount, timing, and periodic monitoring of the progress. This helps researchers effectively manage YK11's side effects. 

• Avoid Stacking YK-11 with Other Compounds: 

Researchers must also avoid stacking YK11 with other compounds. They should only investigate YK11 in a laboratory experiment. This will make it easier for researchers to effectively manage the adverse effects of YK11 during the experiment. 

• Monitor Progress Periodically: 

Researchers must also periodically monitor the progress of the experiment. This will help them to know that their research is on the right track. 

Final Thought 

Despite being beneficial, YK11 may cause side effects in preclinical models; these side effects may include liver toxicity, joint pain, and hormonal fluctuation. Behind these side effects are factors that may alter them. To manage these side effects, researchers must follow the guidelines outlined above. 

Frequently Asked Questions (FAQs)

How long does YK11 stay in the system? 

There is no confirmed half-life for YK11 in the system. However, some preclinical studies suggest it may remain in the system for 24 to 72 hours. 

Does YK11 affect myostatin? 

Yes, YK11 may alter myostatin signaling in preclinical models, thereby affecting muscle hypertrophy. 

Is YK11 neurotoxic? 

We cannot say anything about it, as YK11 has never been studied in clinical trials on humans. 

What is YK11 used for in preclinical studies? 

YK11 is used to observe its impacts on myostatin inhibition and muscle hypertrophy in preclinical models. 

Do SARMs increase libido in preclinical models? 

Yes, preclinical studies suggest that some SARMs may affect pathways associated with libido. 

References: 

1. Lee, Su Jin, et al. "Myostatin inhibitor YK11 as a preventative health supplement for bacterial sepsis." Biochemical and Biophysical Research Communications 543 (2021): 1-7.
2. Dahleh, Mustafa Munir Mustafa, et al. "From gains to gaps? How Selective Androgen Receptor Modulator (SARM) YK11 impacts hippocampal function: In silico, in vivo, and ex vivo perspectives." Chemico-Biological Interactions 394 (2024): 110971.
3. Dahleh, Mustafa Munir Mustafa, et al. "YK11 induces oxidative stress and mitochondrial dysfunction in hippocampus: The interplay between a selective androgen receptor modulator (SARM) and exercise." The Journal of Steroid Biochemistry and Molecular Biology 233 (2023): 106364.
4. Harding, Caitlin, et al. "Equine metabolism of the selective androgen receptor modulator YK‐11 in urine and plasma following oral administration." Drug testing and analysis 15.4 (2023): 388-407.
5. Yatsu, Tomofumi, et al. "Selective androgen receptor modulator, yk11, up-regulates osteoblastic proliferation and differentiation in mc3t3-e1 cells." Biological and Pharmaceutical Bulletin 41.3 (2018): 394-398.
6. Wang, Renyi, et al. "YK11 promotes osteogenic differentiation of BMSCs and repair of bone defects." Journal of Molecular Endocrinology 74.2 (2025).